Glycans in Diseases and Therapeutics
Glycomedicine functions a pivotal role in cell-cell adhesion i.e. a tool utilized by cells of the immune system through sugar-binding proteins called lectins, which identify specific carbohydrate portions. Glycans (carbohydrate oligomers) are the so-called “building blocks” of carbohydrates, nucleic acids, proteins and lipids play foremost roles in numerous biological phenomena as well as in various pathophysiological processes. Many researchers have now understood that glycosylation, i.e. the addition of glycans to a protein backbone, is the most abundant post translational modification reactions and is a significant field of research and sometimes they require a glycobiology method to be exploited.
- Genetic disorder of glycosylations
- Glycoprotein ligand
- Growth factors and oncogenes
- Genetically engineered glycan
Related Conference of Glycans in Diseases and Therapeutics
Glycans in Diseases and Therapeutics Conference Speakers
Recommended Sessions
- Evolution of Glycan Diversity
- Glycan Catabolism and Systemic Physiology
- Glycans in Diseases and Therapeutics
- Glycans in Drug Design
- Glycans in Structural and Computational Systems Biology
- Glycans in Vaccine Development
- Glyco Immunology
- Glycobiology and Biotechnology
- Glycobiology and Glycochemistry
- Glycobiology in Lipid Science
- Glycobiology: It’s Role in Human Health
- Glycoconjugates, Glycomics and Transcriptomics
- Glycomics and Metabolomics
- Glyconeurobiology: Glycans in Neuroscience
- Glycopathology: Glycans in Cancer
- Glycosciences and Monosaccharides
- Mass Spectrometry Analysis
- Recent Advances in Glycobiology
- Structural Bioinformatics and Proteomics
- Synthesis and Biological Role of Glycans